Are you Shannon Willhite Finks?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 5 invites waiting! - Read the latest clinical news, personalized to your specialty.
Education & Training
University of Tennessee Health Science CenterPharmD, 1998
Publications & Presentations
PubMed
- 10 citationsIdarucizumab (Praxbind): The First Reversal Agent for a Direct Oral Anticoagulant.Shannon W. Finks, Kelly C. Rogers
The American Journal of Medicine. 2017-05-01 - 2 citationsPeriprocedural Management of Direct Oral Anticoagulants Surrounding Cardioversion and Invasive Electrophysiological Procedures.Shannon W. Finks, Paul P. Dobesh, Toby C. Trujillo, George H. Crossley
Cardiology in Review. 2018-09-01 - 22 citationsA New Option for Reversing the Anticoagulant Effect of Factor Xa Inhibitors: Andexanet Alfa (ANDEXXA).Kelly C. Rogers, Shannon W. Finks
The American Journal of Medicine. 2019-01-01
Office
University Of Tennessee
881 Madison Avenue, Room 459
Memphis, TN 38163Phone+1 901-448-3701
